{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"Subjects surviving without disease progression 180 days after transplant as evidenced by decreased disease and no new disease showing on radiologic scans and / or bone marrow pathology.","groups":[{"description":"Single Arm Intervention trial as noted in interventions section\n\nFludarabine: Fludarabine 30 mg/m2/day x 3 days\n\nTotal Body Irradiation: TBI 200cGy x1 dose on transplant day\n\nInfusion of Stem Cells: On Day 0 pts will received an infusion of HLA matched sibling donor stem cells. Dose is determined by the volume of cells obtained from donor. Minimum dose is 2x10\\*6 CD34+ cells per kilogram of recipient weight.","id":"OG000","title":"Single Arm Trial"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"180 days post transplant","title":"Progressive Free Survival Post Transplant","type":"PRIMARY","unitOfMeasure":"participants"}